Allon Therapeutics Inc.
NPCUF
$0.0001
$0.000.00%
OTC PK
| 03/31/2013 | 12/31/2012 | 09/30/2012 | 06/30/2012 | 03/31/2012 | |
|---|---|---|---|---|---|
| Net Income | -4.65% | -15.96% | 29.56% | 20.42% | 19.49% |
| Total Depreciation and Amortization | -29.92% | -6.11% | -3.25% | -0.42% | 1.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,218.41% | 1,639.95% | 108.87% | 95.19% | 38.24% |
| Change in Net Operating Assets | 28.71% | 97.92% | -112.07% | -28.49% | -81.72% |
| Cash from Operations | 31.21% | 21.00% | 4.63% | 21.74% | 1.85% |
| Capital Expenditure | -- | -- | 100.00% | 89.92% | 74.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -100.00% | -104.74% | -120.39% |
| Total Debt Issued | -100.00% | -- | -75.08% | -75.08% | -75.08% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 105.80% | 132.12% | 7,636.77% | 7,636.77% | 2,457.65% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -205.45% | -205.41% | -- | -- | -- |
| Cash from Financing | -14.45% | 96.36% | 39.83% | 39.77% | -23.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 67.18% | 102.53% | 270.40% | 255.18% | -163.80% |